Next report date
Report period
Q1 2024
EPS estimate
−4.56USD
Revenue estimate
—
−22.56 MUSD
420.00 KUSD
1.20 M
Om Cyclacel Pharmaceuticals, Inc.
Sektor
Bransch
VD
Spiro Rombotis
Webbplats
Huvudkvarter
Berkeley Heights
Grundat
1996
FIGI
BBG000CT3XM2
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
